Skip to main content
SpringerLink
Log in
Book cover

Pearls of Glaucoma Management pp 273–278Cite as

Medical Treatment: Adherence and Persistence

  • Chapter
  • First Online:

  • 1103 Accesses

Abstract

Chronic medical therapy for a largely asymptomatic disease is discussed focusing on issues including persistence and adherence to topical therapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Berg JS, Dischler J, Wagner DJ, Raja JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27 Suppl 9:S1–24.

    CAS  PubMed  Google Scholar 

  2. Dawn AG, Santiago-Turla C, Lee PP. Patient expectations regarding eye care focus group results. Arch Ophthalmol. 2003;121:762–8.

    Article  PubMed  Google Scholar 

  3. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology of the glaucoma adherence and persistence study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052–7.

    Article  PubMed  Google Scholar 

  4. Herndon LW, Brunner TM, Rollins JN. The glaucoma research foundation patient survey: patient understanding of glaucoma and its treatment. Am J Ophthalmol. 2006;141:S22–7.

    Article  PubMed  Google Scholar 

  5. Jackevicius CA, Mamdani M, Tu JV. Adherence in statin therapy in elderly patients with and without acute coronary syndrome. JAMA. 2002;288:462–7.

    Article  PubMed  Google Scholar 

  6. Kass MA, Heuer DK, Higginbotham EJ, For Ocular Hypertension Treatment Study Group, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–13.

    Article  PubMed  Google Scholar 

  7. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515–23.

    Article  CAS  PubMed  Google Scholar 

  8. Kosoko O, Quigley HA, Vitale S, et al. Risk factors for non-compliance with glaucoma follow-up visits. Ophthalmology. 1998;105:2105–11.

    Article  CAS  PubMed  Google Scholar 

  9. Levy G, Zamacona MK, Jusko WJ. Developing compliance instructions for drug labeling. Clin Pharmacol Ther. 2000;68:586–91.

    Article  CAS  PubMed  Google Scholar 

  10. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331–6.

    Article  PubMed  Google Scholar 

  11. Nordstrom B, Friedman D, Mozaffari E, Quigley H, Walker A. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598–606.

    Article  PubMed  Google Scholar 

  12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–95.

    Article  CAS  PubMed  Google Scholar 

  13. Owsley C, McGwin G, Scilley K, et al. Perceived barriers to care and attitudes about vision and eye care: focus groups with older African Americans and eye care providers. Invest Ophthalmol Vis Sci. 2006;47:2797–802.

    Article  PubMed  Google Scholar 

  14. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26:233–6.

    CAS  PubMed  Google Scholar 

  15. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol. 2004;137 Suppl 1:S3–12.

    Article  PubMed  Google Scholar 

  16. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126–32.

    CAS  PubMed  Google Scholar 

  17. Sloan FA, Brown DS, Carlisle ES, et al. Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res. 2004;39:1429–48.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Stewart WC, Konstas AG, Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther. 2004;20:461–9.

    Article  CAS  PubMed  Google Scholar 

  19. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12:393–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glaucoma Consultants Northwest, Arnold Medical Pavilion, 1221 Madison Street, Suite 1124, Seattle, WA, 98104, USA

    Annisa L. Jamil M.D. & Richard P. Mills M.D.

Authors
  1. Annisa L. Jamil M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard P. Mills M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annisa L. Jamil M.D. .

Editor information

Editors and Affiliations

  1. David Geffen School of Medicine, University of California at Los Angeles, Veterans Health Administration of Greater Los Angeles, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Veterans Health Administration of Greater Los Angeles, Los Angeles, California, USA

    JoAnn A. Giaconi

  2. David Geffen School of Medicine, University of California at Los Angeles, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Simon K. Law

  3. David Geffen School of Medicine, University of California at Los Angeles,, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Kouros Nouri-Mahdavi

  4. David Geffen School of Medicine, University of California at Los Angeles,, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Anne L. Coleman

  5. David Geffen School of Medicine, University of California at Los Angeles,, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Joseph Caprioli

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jamil, A.L., Mills, R.P. (2016). Medical Treatment: Adherence and Persistence. In: Giaconi, J., Law, S., Nouri-Mahdavi, K., Coleman, A., Caprioli, J. (eds) Pearls of Glaucoma Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49042-6_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-49042-6_30

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-49040-2

  • Online ISBN: 978-3-662-49042-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation